Inactive Instrument
Epigenomics AG Stock Xetra
Stocks
DE000A1K0516
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Xetra
|
||
| - EUR | - |
|
| 03/09 | Epigenomics AG Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 02/04 | Epigenomics AG Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 798K 895K 743K 677K 1.27M 86.15M 1.28M 8.98M 3.5M 43.97M 3.36M 3.29M 141M | P/E 2024 |
-0.29x | P/E 2025 | -2.51x |
|---|---|---|---|---|---|
| Enterprise Value | 11.77M 13.19M 10.96M 9.97M 18.78M 1.27B 18.92M 132M 51.53M 648M 49.51M 48.44M 2.08B | EV / Sales 2024 |
-
| EV / Sales 2025 | 490x |
| Free-Float |
70.75% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Frederic Hilke
IRC | Investor Relations Contact | - | - |
| Corporate Officer/Principal | 55 | 01/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Helge Lubenow
CHM | Chairman | 58 | 01/03/2023 |
Alexander Link
BRD | Director/Board Member | 55 | 01/06/2020 |
Jochen Hummel
BRD | Director/Board Member | 56 | 05/02/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.16% | +3.42% | +49.37% | +94.17% | 74.31B | |
| -0.37% | -3.81% | +19.75% | +78.12% | 56.95B | |
| +1.63% | -1.61% | +3.83% | +36.89% | 48.3B | |
| +0.50% | +2.94% | +344.62% | +722.17% | 44.51B | |
| +3.05% | -1.80% | +28.78% | +34.51% | 43.8B | |
| +1.00% | -1.46% | +5.17% | +111.90% | 41.12B | |
| -0.54% | +2.41% | +9.31% | +58.85% | 31.07B | |
| +4.06% | +7.57% | +37.02% | +31.69% | 28.97B | |
| +0.76% | -1.45% | -7.44% | -11.12% | 24.53B | |
| Average | +1.56% | -0.15% | +54.49% | +128.58% | 43.73B | |
| Weighted average by Cap. | +1.72% | -0.46% | +58.37% | +137.11% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 24K 26.9K 22.36K 20.35K 38.32K 2.59M 38.6K 270K 105K 1.32M 101K 98.81K 4.25M |
| Net income | -3.35M -3.76M -3.12M -2.84M -5.35M -362M -5.39M -37.73M -14.68M -185M -14.11M -13.8M -594M | -314K -352K -293K -266K -501K -33.9M -505K -3.53M -1.38M -17.3M -1.32M -1.29M -55.61M |
| Net Debt | 10.46M 11.72M 9.74M 8.86M 16.69M 1.13B 16.82M 118M 45.79M 576M 44M 43.05M 1.85B | 10.97M 12.29M 10.22M 9.3M 17.51M 1.18B 17.64M 123M 48.03M 604M 46.15M 45.15M 1.94B |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
